abaloparatide-solid microstructured transdermal system
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for abaloparatide-solid microstructured transdermal system, covering 2023-02-15 to 2023-02-15. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis [Phase 3]